COR Stock Analysis: Buy, Sell, or Hold?
COR - Cencora, Inc.
$309.93
-2.52 (-0.81%)
▼
5d:
-3.33%
30d:
-16.72%
90d:
-9.12%
BUY
HIGH Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 06, 2026
Smart Money Accumulation
COR is down 3.2% this week, but smart money is accumulating calls. Top strike: $330 2026-05-15 with 364 OI. Call ratio: 73% View Scanner →
Strength: 3.9/10
Get Alerted When COR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: COR trading at deep discount. Market pricing in -5.1% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: COR trading at deep discount. Market pricing in -5.1% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$522.79
Based on 7.7% avg growth
INTRINSIC VALUE TODAY
$324.61
4.5% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 18.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: COR is currently trading at $309.93, which is considered oversold relative to its 30-day fair value range of $331.39 to $367.74. From a valuation perspective, the stock is trading at a discount (Forward PE: 15.8) compared to its historical average (18.4). Remarkably, the market is currently pricing in an annual earnings decline of 5.1% over the next few years. This pessimistic expectation contrasts with the company's recent 14.8% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, COR is in a downtrend. The price is currently testing key support at $310.23. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $407.92 (+31.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, COR is in a downtrend. The price is currently testing key support at $310.23. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $407.92 (+31.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$331.39 -
$367.74
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 31.6% below Wall St target ($407.92)
Fair Price Analysis
30-Day Fair Range
$331.39 -
$367.74
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$310.23
Resistance Level
$342.15
Current Trend
Downtrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
15.78
Wall Street Target
$407.92
(+31.6%)
Revenue Growth (YoY)
5.5%
Earnings Growth (YoY)
14.8%
Profit Margin
0.5%
Valuation Discount vs History
-5.1% cheaper
PE vs Historical
15.8 vs 18.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-5.1%
(market-implied from PE analysis)
1-Year Target
$294.12
(-5%)
2-Year Target
$279.12
(-10%)
3-Year Target
$264.89
(-15%)
3-Yr Target (if PE normalizes)
(PE: 16→18)
$308.81
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 11.4%)
$607.40
(+96%)
Base:
(SPY PE: 15.8, Growth: 11.4%)
$428.93
(+38%)
Bear:
(PE: 13.4, Growth: 11.4%)
$364.59
(+18%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (39x PE), but valuation improves significantly next year (16x PE) as earnings recover.
Trailing PE: 39.20 | Current EPS (TTM): $8.34
Bull Case
$719.20
(+124%)
Analyst growth 100.0%, PE expands to 43.1
Base Case
$653.82
(+104%)
Market implied 100.0%, PE stable at 39.2
Bear Case
$222.30
(-31%)
Severe decline -20.0%, PE contracts to 33.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 15.8 to 18.4
Stabilization Target:
$361.32
(+16.6%)
PE Expansion Potential:
+16.6%
Share & Embed Analysis
Last updated: March 30, 2026 5:54 PM ET
Data refreshes hourly during market hours. Next update: 6:54 PM
Data refreshes hourly during market hours. Next update: 6:54 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is COR showing a specific setup today?
Insider Activity (6 Months)
1
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
BUY
2026-01-29
Robert P Mauch
SELL
5096 shares
2026-01-20
Elizabeth S Campbell
SELL
3351 shares
2025-12-19
Featured in Portfolios
COR is a key holding in these high-performance investment strategies.
Top Rated Medical Distribution Stocks
Top-rated stocks in Medical Distribution by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
MCK
McKesson Corporation |
STRONG BUY
17 analysts |
$998 | 61 BUY |
|
CAH
Cardinal Health Inc |
BUY
17 analysts |
$250 | 52 HOLD |
|
HSIC
Henry Schein Inc |
HOLD
16 analysts |
$90 | 60 HOLD |
|
QIPT
Quipt Home Medical Corp |
STRONG BUY
5 analysts |
$4 | 53 HOLD |
|
OMI
Owens & Minor Inc |
HOLD
6 analysts |
$6 | 53 HOLD |
Advanced COR Option Strategies
Professional options setups generated by AI based on today's COR price and gamma walls.
